Original research
by
Kitchen, Sophie A. et al
Release Date
2022
Geography
Canada
Language of Resource
English
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
Investigated the impact of the expansion in eligibility for take-home doses on trends in the distribution of take-home doses of OAT during COVID-19.
Findings/Key points
The new guidance for dispensing OAT in Ontario resulted in increases in the duration of take-home doses of methadone and buprenorphine/naloxone supplied. However, given that changes were small, strategies to improve retention in OAT and ensure equitable access to take-home dosing should continue.
Design/methods
Population-based time series analysis (June 2019-November 2020)
Keywords
Substitution/OAT
Policy/Regulatory
Overdose
Evidence base
Carries/take-home doses
